American Academy of Child and Adolescent Psychiatry 59th Annual Meeting Program Schedule
Please note that this schedule is subject to change.

New Research Poster Presentation 5.42
Aripiprazole for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients: Insight Into the Emergence and Resolution of Adverse Events
Friday, October 26, 2012
Raun Melmed, M.D., Melmed Center, Southwest Autsim Research and Resource Center, Scottsdale, AZ
Samantha Min, M.B.A., Pharm.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Carlsbad, CA
Jessie Chambers, PhD, Otsuka Pharmaceutical Development and Commercialization, Inc., Albuquerque, NM
Sabrina V. Marler, MS, Research and Development, Bristol-Myers Squibb, Wallingford, CT
Ronald N. Marcus, MD, Research and Development, Bristol-Myers Squibb, Wallingford, CT
Robert D. McQuade, PhD, Global Medical and Regulatory Affairs and Scientific Alliances, Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
Raymond Mankoski, M.D., Ph.D., Research and Development, Bristol-Myers Squibb, Plainsboro, NJ
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.